Venus Medtech (Hangzhou) Balance Sheet Health
Financial Health criteria checks 3/6
Venus Medtech (Hangzhou) has a total shareholder equity of CN¥2.9B and total debt of CN¥705.9M, which brings its debt-to-equity ratio to 24.2%. Its total assets and total liabilities are CN¥4.4B and CN¥1.5B respectively.
Key information
24.2%
Debt to equity ratio
CN¥705.91m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥781.64m |
| Equity | CN¥2.92b |
| Total liabilities | CN¥1.49b |
| Total assets | CN¥4.41b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VMTH.F's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥805.2M).
Long Term Liabilities: VMTH.F's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥689.2M).
Debt to Equity History and Analysis
Debt Level: VMTH.F has more cash than its total debt.
Reducing Debt: VMTH.F's debt to equity ratio has increased from 17% to 24.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VMTH.F has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: VMTH.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 28.4% each year